Skip to main content

Table 1 Clinical and biochemical traits of the study subjects. OBO, obesity only and OBM, obesity with metabolic syndrome. Significance was determined by the Student’s t-test

From: An integrated multi-omic approach demonstrates distinct molecular signatures between human obesity with and without metabolic complications: a case–control study

Feature

OBO N = 18

OBM N = 21

P Value

Age (years)

38.1 ± 4.2

40.5 ± 7.3

0.283

Females (N; %)

11 (61%)

9 (42.9%)

0.415

Height (cm)

167.4 ± 11.9

170.8 ± 9.6

0.370

Weight (kg)

113.4 ± 19.6

110.9 ± 27.6

0.782

BMI (kg/m2)

40.0 ± 4.5

39.6 ± 3.0

0.746

Smoking (%)

6.0

33.0

0.027

HBA1c (%)

5.5 ± 0.27

7.02 ± 1.9

0.002

Fasting triglycerides (mmol/L)

1.39 ± 0.48

2.65 ± 1.52

0.001

Total Cholesterol (mmol/L)

4.9 ± 1.1

4.8 ± 1.1

0.855

LDL-Cholesterol (mmol/L)

2.8 ± 1.3

2.6 ± 1.1

0.728

HDL-Cholesterol (mmol/L)

1.5 ± 0.7

1.0 ± 0.3

0.008

Fasting glucose (mmol/L)

5.2 ± 0.6

7.4 ± 3.4

0.009

Creatinine (μmol/L)

67.5 ± 14.1

65.3 ± 14.1

0.563

Fasting insulin (miU/mL)

19.0 ± 13.3

27.6 ± 13.2

0.053

C-reactive protein (mg/L)

12.8 ± 12.5

7.1 ± 4.5

0.064

Alanine transaminase (U/L)

20.7 ± 11.6

36.5 ± 35.1

0.063

Aspartate aminotransferase (U/L)

18.8 ± 9.6

23.6 ± 15.0

0.251